Study Name:

Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

 

 

 

         

Purpose:

 The COMPLETE registry is a prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices. This study is designed to better understand PTCL patient characteristics, treatments, and outcomes to help design and understand future clinical trials.

Study Type: Observational

Protocol: UIC 2010-0683 COMPLETE

 

For study details, click here.

Internal users only: click here for protocol details and forms.

Study Name:

A Phase II Open-label Study of Single Agent Ofatumumab in Patients With Relapsed and/or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas

         

Purpose:

This is a phase II open label study that looks at the efficacy and toxicity of Ofatumumab monotherapy in patients with relapsed and/or refractory DLBCL.

Study Type: Treatment

Protocol: OFT 113588

 

For study details, click here.

Internal users only: click here for protocol details and forms.

Study Name:

A Randomized Phase II Trial of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib (NSC # 681239, IND # 58443) and Bendamustine in Patients With Untreated Follicular Lymphoma.

         

Purpose:

This randomized phase II clinical trial is studying how well ofatumumab and bendamustine hydrochloride with or without bortezomib works in treating patients with untreated follicular non-Hodgkin lymphoma.

Study Type: Treatment

Protocol: CALGB 50904

 

For study details, click here.

Internal users only: click here for protocol details and forms.

Study Name:

Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response.

         

Purpose:

This study will evaluate the effectiveness of a type of blood stem cell transplant that uses lower doses of chemotherapy in people with relapsed follicular non-Hodgkin's lymphoma.

Study Type: Treatment

Protocol: UIC 2009-0505 BMT CTN Study 0701

 

For study details, click here.

Internal users only: click here for protocol details and forms.

Study Name:

Phase III Randomized Study of R-CHOP versus Dose Adjusted EPOCH-R with Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas.

 

         

Purpose:

This randomized phase III trial is studying rituximab when given together with two different combination chemotherapy regimens to compare how well they work in treating patients with diffuse large B-cell non-Hodgkin's lymphoma.

Study Type: Treatment

Protocol: UIC 2008-0992 CALGB 50303

 

For study details, click here.

Internal users only: click here for protocol details and forms.

Back to Oncology Clinical Trials Homepage